Astana Biomed Group, an authorized Abcam distributor in Central Asia

Human SLC11A2 knockout HeLa cell pellet (ab279005)

Overview

  • Product name

    Human SLC11A2 knockout HeLa cell pellet

  • Product overview

    Abcam’s knockout cell pellets give you access to native proteins, without the need to culture cells. Our knockout cell pellets are prepared from our single-gene knockout cell lines and provide an additional offering to our cell lysates.

    Cells are snap-frozen to provide high quality pellets that are suitable for extraction with alternative lysis buffers or for preparation of lysates from subcellular fractions. Our knockout cell pellets are suitable for a variety of applications, including PCR, gene expression profiling and DNA library preparation.

  • Parental Cell Line

    HeLa

  • Organism

    Human

  • Mutation description

    Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon2 and 5 bp deletion in exon2.

  • Passage number

  • Knockout validation

    Sanger Sequencing

  • Notes

    Pellet size: 5 million cells/vial.

    This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

Properties

Properties

Images

  • Sanger Sequencing - Human SLC11A2 knockout HeLa cell pellet (ab279005)
    Sanger Sequencing - Human SLC11A2 knockout HeLa cell pellet (ab279005)

    Allele-1: 5 bp deletion in exon2

     

  • Sanger Sequencing - Human SLC11A2 knockout HeLa cell pellet (ab279005)
    Sanger Sequencing - Human SLC11A2 knockout HeLa cell pellet (ab279005)

    Allele-2: 2 bp deletion in exon2

     

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up